Clinical Trial Update: Treatment of Mycobacterium Xenopi Pulmonary Infection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating treatment for Mycobacterium xenopi pulmonary infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Xenopi Pulmonary Disease

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Atypical; Mycobacterium, Pulmonary, Tuberculous | Phase 3 | Status: COMPLETED